HOME
Donate now
EN FR
EN FR

Cancer Surveillance Branch (CSU)

Publications

All recent publications: 2025-2021

View Key Publications

 

  1. Fedoriw Y, Silva O, Znaor A, Macintyre E (2025). Global view of haematolymphoid tumor classifications and their application in low- and middle-income countries. Histopathology. 86(1): 6-16. https://doi.org/10.1111/his.15340 PMID:39420576
  2. Mezger NCS, Seraphin TP, Balle R, Griesel M, Joko-Fru YW, Hammerl L, et al. (2025). NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers. Journal of the National Cancer Institute. 117(1): 120-133. https://doi.org/10.1093/jnci/djae221 PMID:39269229
  3. Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, et al. (2025). Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncology. 26(1): 51-63. https://doi.org/10.1016/S1470-2045(24)00600-4 PMID:39674189
  4. Abu Awwad D, Shafiq J, Delaney GP, Anacak Y, Bray F, Flores JA, et al. (2024). Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis. Lancet Oncology. 25(2): 225-234. https://doi.org/10.1016/S1470-2045(23)00619-8 PMID:38301690
  5. Alessy SA, Alqahtani SA, Vignat J, Abuhmaidan A, Basmi AEL, Al Lawati N, et al. (2024). The current and future cancer burden in the Gulf Cooperation Council (GCC) countries. Cancer Med. 13(17): e70141. https://doi.org/10.1002/cam4.70141 PMID:39279725
  6. Benitez Fuentes JD, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. (2024). Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis. JAMA Oncol. 10(1): 71-78. https://doi.org/10.1001/jamaoncol.2023.4837 PMID:37943547
  7. Benitez Fuentes JD, Morgan E, Soerjomataram I (2024). Clarification Regarding Breast Cancer Stage in France-Reply. JAMA Oncol. 10(6): 832-833. https://doi.org/10.1001/jamaoncol.2024.0671 PMID:38662350
  8. Bray F (2024). Cancer trends in the UK. BMJ. 384: q504. https://doi.org/10.1136/bmj.q504 PMID:38479756
  9. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 74(3): 229-263. https://doi.org/10.3322/caac.21834 PMID:38572751
  10. Businge L, Hagenimana M, Motlhale M, Bardot A, Liu B, Anastos K, et al. (2024). Stage at diagnosis and survival by stage for the leading childhood cancers in Rwanda. Pediatric Blood & Cancer. 71(7): e31020. https://doi.org/10.1002/pbc.31020 PMID:38668553
  11. Corredor C, Pineros M, Wiesner C, de Vries E (2024). Using administrative registries as a source for population-based cancer incidence and mortality. BMC Cancer. 24(1): 232. https://doi.org/10.1186/s12885-023-11754-w PMID:38373947
  12. de Paula Silva N, Colombet M, Moreno F, Erdmann F, Dolya A, Pineros M, et al. (2024). Incidence of childhood cancer in Latin America and the Caribbean: coverage, patterns, and time trends. Revista Panamericana de Salud Publica. 48: e11. https://doi.org/10.26633/RPSP.2024.11 PMID:38410357
  13. de Paula Silva N, Gini A, Dolya A, Colombet M, Soerjomataram I, Youlden D, et al. (2024). Prevalence of childhood cancer survivors in Europe: a scoping review. EJC Paediatr Oncol. 3: None. https://doi.org/10.1016/j.ejcped.2024.100155 PMID:38915419
  14. Fantin R, Sierra MS, Vaccarella S, Herrero R, Barboza-Solis C (2024). Social gradient and rural-urban disparities in cancer mortality in Costa Rica. Cancer Epidemiology. 91: 102604. https://doi.org/10.1016/j.canep.2024.102604 PMID:38941875
  15. Ghasemi-Kebria F, Fazel A, Semnani S, Etemadi A, Naeimi-Tabiei M, Hasanpour-Heidari S, et al. (2024). Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018. Cancer Epidemiology. 89: 102525. https://doi.org/10.1016/j.canep.2024.102525 PMID:38228040
  16. Gizaw M, Parkin DM, Stoter O, Bukirwa P, Seife E, Chesumbai G, et al. (2024). Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study. International Journal of Cancer. 154(11): 1911-1919. https://doi.org/10.1002/ijc.34877 PMID:38339849
  17. Guimaraes Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F (2024). Ethnic disparities in cancer mortality in the capital and northeast of the State of Sao Paulo, Brazil 2001-17. Cancer Causes and Control. 35(3): 523-529. https://doi.org/10.1007/s10552-023-01812-w PMID:37917366
  18. Hagenimana M, Motlhale M, Parkin DM, Businge L, Bardot A, Liu B, et al. (2024). Stage at diagnosis and survival among adult patients with cancer in Rwanda: A population-based study. International Journal of Cancer. 155(6): 988-995. https://doi.org/10.1002/ijc.34969 PMID:38888375
  19. Islami F, Marlow EC, Thomson B, McCullough ML, Rumgay H, Gapstur SM, et al. (2024). Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA: A Cancer Journal for Clinicians. 74(5): 405-432. https://doi.org/10.3322/caac.21858 PMID:38990124
  20. James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 403(10437): 1683-1722. https://doi.org/10.1016/S0140-6736(24)00651-2 PMID:38583453
  21. Joko-Fru WY, Bardot A, Bukirwa P, Amidou S, N’da G, Woldetsadik E, et al. (2024). Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study. Lancet Glob Health. 12(6): e947-e959. https://doi.org/10.1016/S2214-109X(24)00130-X PMID:38762297
  22. Kenessey I, Parrag P, Dobozi M, Szatmari I, Weber A, Nagy P, et al. (2024). The epidemiology of lung cancer in Hungary based on the characteristics of patients diagnosed in 2018. Scientific Reports. 14(1): 20064. https://doi.org/10.1038/s41598-024-70143-w PMID:39209889
  23. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al. (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4): eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID:38277453
  24. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. International Journal of Cancer. 154(2): 389-402. https://doi.org/10.1002/ijc.34710 PMID:37694289
  25. Li M, Dal Maso L, Pizzato M, Vaccarella S (2024). Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes and Endocrinology. 12(11): 824-836. https://doi.org/10.1016/S2213-8587(24)00223-7 PMID:39389067
  26. Mafra A, Laversanne M, Marcos-Gragera R, Chaves HVS, McShane C, Bray F, et al. (2024). The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae321 PMID:39658225
  27. Malagon T, Franco EL, Tejada R, Vaccarella S (2024). Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nature Reviews: Clinical Oncology. 21(7): 522-538. https://doi.org/10.1038/s41571-024-00904-z PMID:38760499
  28. Moen L, Liu B, Bukirwa P, Chingonzoh T, Chokunonga E, Finesse A, et al. (2024). Trends in the incidence of colorectal cancer in sub-Saharan Africa: A population-based registry study. International Journal of Cancer. 155(4): 675-682. https://doi.org/10.1002/ijc.34942 PMID:38568397
  29. Moreira DC, Znaor A, Santana VM, Dolya A, Fox Irwin L, Bhakta N, et al. (2024). Expanding the Global Capacity for Childhood Cancer Registration: The ChildGICR Masterclass. JCO Glob Oncol. 10: e2300334. https://doi.org/10.1200/GO.23.00334 PMID:38905577
  30. Morgan E, O’Neill C, Bardot A, Walsh P, Woods RR, Gonsalves L, et al. (2024). Collecting Long-Term Outcomes in Population-Based Cancer Registry Data: The Case of Breast Cancer Recurrence. JCO Glob Oncol. 10: e2400249. https://doi.org/10.1200/GO-24-00249 PMID:39481072
  31. Morgan E, O’Neill C, Shah R, Langselius O, Su Y, Frick C, et al. (2024). Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis. Breast Cancer Research. 26(1): 171. https://doi.org/10.1186/s13058-024-01881-y PMID:39605105
  32. Murthy SS, Trapani D, Cao B, Bray F, Murthy S, Kingham TP, et al. (2024). Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000-19: a retrospective, cross-sectional, population-based study. Lancet Oncology. 25(8): 969-978. https://doi.org/10.1016/S1470-2045(24)00274-2 PMID:38964357
  33. Pineros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, et al. (2024). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? International Journal of Cancer. https://doi.org/10.1002/ijc.35232 PMID:39580808
  34. Poudel KK, Singh D, Sims DJ (2024). Gastric Cancer Survival and Its Predictors in Nepal. Asian Pacific Journal of Cancer Prevention. 25(10): 3635-3642. https://doi.org/10.31557/APJCP.2024.25.10.3635 PMID:39471031
  35. Radhakrishnan V, Jothi A, Mary R, Veeraiah S, Sudhakar R, Selvam P, et al. (2024). Assessment of Barriers and Enablers for Implementing a Population-Based Childhood Cancer Registry in Chennai, India. Pediatric Blood & Cancer: e31500. https://doi.org/10.1002/pbc.31500 PMID:39739444
  36. Rahman MS, Rahman MM, Acharya K, Haruyama R, Shah R, Matsuda T, et al. (2024). Disparities and Determinants of Testing for Early Detection of Cervical Cancer among Nepalese Women: Evidence from a Population-Based Survey. Cancer Epidemiology, Biomarkers and Prevention. 33(8): 1046-1056. https://doi.org/10.1158/1055-9965.EPI-24-0037 PMID:38820125
  37. Reid F, Adams T, Adel RS, Andrade CE, Bajwa A, Bambury IG, et al. (2024). The every woman study low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer. PloS One. 19(5): e0298154. https://doi.org/10.1371/journal.pone.0298154 PMID:38809901
  38. Rey Brandariz J, Rumgay H, Ayo-Yusuf O, Edwards R, Islami F, Liu S, et al. (2024). Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. Lancet Public Health. 9(10): e745-e754. https://doi.org/10.1016/S2468-2667(24)00185-3 PMID:39366730
  39. Rey Brandariz J, Rumgay H, Ayo-Yusuf O, Edwards R, Islami F, Liu S, et al. (2024). Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study. Lancet Public Health. 9(10): e745-e754. https://doi.org/10.1016/S2468-2667(24)00185-3 PMID:39366730
  40. Ritter J, de Braganca J, Auste C, Mendez A, Cohen PD, Fajardo AF, et al. (2024). Novel Framework of Financial Hardship in Childhood Cancer: Incorporating Stakeholder Perspectives. JCO Glob Oncol. 10: e2400093. https://doi.org/10.1200/GO.24.00093 PMID:39208390
  41. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncology. 25(11): 1413-1423. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID:39393386
  42. Shah R, Battisti NML, Brain E, Gnangnon FHR, Kanesvaran R, Mohile S, et al. (2024). Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates. Cancer Epidemiology: 102716. https://doi.org/10.1016/j.canep.2024.102716 PMID:39603975
  43. Shah R, Loo CE, Hanna NM, Hughes S, Mafra A, Fink H, et al. (2024). Global review of COVID-19 mitigation strategies and their impact on cancer service disruptions. J Cancer Policy. 41: 100486. https://doi.org/10.1016/j.jcpo.2024.100486 PMID:38830535
  44. Smith CDL, McMahon AD, Lyall DM, Goulart M, Inman GJ, Ross A, et al. (2024). Development and external validation of a head and neck cancer risk prediction model. Head and Neck. 46(9): 2261-2273. https://doi.org/10.1002/hed.27834 PMID:38850089
  45. Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G, et al. (2024). Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies. Alcohol Clin Exp Res (Hoboken). 48(12): 2222-2241. https://doi.org/10.1111/acer.15493 PMID:39581746
  46. Steinberg J, Hughes S, Hui H, Allsop MJ, Egger S, David M, et al. (2024). Risk of COVID-19 death for people with a pre-existing cancer diagnosis prior to COVID-19-vaccination: A systematic review and meta-analysis. International Journal of Cancer. 154(8): 1394-1412. https://doi.org/10.1002/ijc.34798 PMID:38083979
  47. Stoer NC, Vangen S, Singh D, Fortner RT, Hofvind S, Ursin G, et al. (2024). Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway. British Journal of Cancer. 131(1): 126-137. https://doi.org/10.1038/s41416-024-02590-1 PMID:38740969
  48. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, et al. (2024). Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 15(1): 7835. https://doi.org/10.1038/s41467-024-51679-x PMID:39244563
  49. Trias-Llimos S, Renteria E, Rutigliano R, Aggarwal A, Moodley J, Unger-Saldana K, et al. (2024). Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019. Journal of the National Cancer Institute. 116(12): 1934-1941. https://doi.org/10.1093/jnci/djae191 PMID:39141445
  50. Vaccarella S, Li M, Bray F, Kvale R, Serraino D, Lorenzoni V, et al. (2024). Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study. BMJ. 386: e077738. https://doi.org/10.1136/bmj-2023-077738 PMID:39231588
  51. Wang S, Zheng R, Li J, Zeng H, Li L, Chen R, et al. (2024). Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN. Lancet Gastroenterol Hepatol. 9(3): 229-237. https://doi.org/10.1016/S2468-1253(23)00366-7 PMID:38185129
  52. Weber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P, et al. (2024). Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World Journal of Urology. 42(1): 237. https://doi.org/10.1007/s00345-024-04949-8 PMID:38625417
  53. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2024). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tobacco Control. 33(3): 295-301. https://doi.org/10.1136/tc-2022-057262 PMID:36100264
  54. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. International Journal of Cancer. 154(1): 28-40. https://doi.org/10.1002/ijc.34671 PMID:37615573
  55. Znaor A, Eser S, Bendahhou K, Shelpai W, Al Lawati N, A EL, et al. (2024). Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study. International Journal of Cancer. 155(1): 54-60. https://doi.org/10.1002/ijc.34895 PMID:38456478
  56. Ali M, Nusselder W, Weiderpass E, Corbex M, Bray F, Vaccarella S (2023). Inequities in cancer outcomes. Bulletin of the World Health Organization. 101(9): 550. https://doi.org/10.2471/BLT.23.290661 PMID:37663873
  57. Banham D, Roder D, Thompson S, Williamson A, Bray F, Currow D (2023). The effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales. Cancer Causes and Control. 34(10): 909-926. https://doi.org/10.1007/s10552-023-01727-6 PMID:37329444
  58. Barchuk A, Tursun-Zade R, Nazarova E, Komarov Y, Tyurina E, Tumanova Y, et al. (2023). Completeness of regional cancer registry data in Northwest Russia 2008-2017. BMC Cancer. 23(1): 994. https://doi.org/10.1186/s12885-023-11492-z PMID:37853404
  59. Bauer M, Vetter M, Stuckrath K, Yohannes M, Desalegn Z, Yalew T, et al. (2023). Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 11(6): 720-731. https://doi.org/10.1158/2326-6066.CIR-22-0795 PMID:37058582
  60. Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. (2023). 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. European Urology. 84(2): 191-206. https://doi.org/10.1016/j.eururo.2023.04.021 PMID:37202314
  61. Blanco-Lopez J, Iguacel I, Pisanu S, Almeida CCB, Steliarova-Foucher E, Sierens C, et al. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 20(7): 5428. https://doi.org/10.3390/ijerph20075428 PMID:37048042
  62. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. International Journal of Cancer. 152(10): 2069-2080. https://doi.org/10.1002/ijc.34444 PMID:36694401
  63. Cabasag CJ, Arnold M, Rutherford M, Ferlay J, Bardot A, Morgan E, et al. (2023). Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study. International Journal of Cancer. 152(9): 1763-1777. https://doi.org/10.1002/ijc.34403 PMID:36533660
  64. Chen JG, Chen HZ, Zhu J, Shen AG, Sun XY, Parkin DM (2023). Cancer survival: left truncation and comparison of results from hospital-based cancer registry and population-based cancer registry. Frontiers in Oncology. 13: 1173828. https://doi.org/10.3389/fonc.2023.1173828 PMID:37350938
  65. De Camargo Cancela M, Monteiro Dos Santos JE, Lopes de Souza LB, Martins LFL, Bezerra de Souza DL, Barchuk A, et al. (2023). The economic impact of cancer mortality among working-age individuals in Brazil from 2001 to 2030. Cancer Epidemiology. 86: 102438. https://doi.org/10.1016/j.canep.2023.102438 PMID:37579673
  66. Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Ferlay J, Bray F, et al. (2023). Global burden of HPV-attributable squamous cell carcinoma of the anus in 2020, according to sex and HIV status: A worldwide analysis. International Journal of Cancer. 152(3): 417-428. https://doi.org/10.1002/ijc.34269 PMID:36054026
  67. Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. (2023). Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 11(11): e1700-e1712. https://doi.org/10.1016/S2214-109X(23)00406-0 PMID:37774721
  68. Ghasemi-Kebria F, Jafari-Delouie N, Semnani S, Fazel A, Etemadi A, Norouzi A, et al. (2023). Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018. Cancer Epidemiology. 86: 102415. https://doi.org/10.1016/j.canep.2023.102415 PMID:37442047
  69. Ghasemi-Kebria F, Semnani S, Fazel A, Etemadi A, Amiriani T, Naeimi-Tabiei M, et al. (2023). Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018. International Journal of Cancer. 153(1): 73-82. https://doi.org/10.1002/ijc.34518 PMID:36943026
  70. Gini A, Colombet M, de Paula Silva N, Visser O, Youlden D, Soerjomataram I, et al. (2023). A new method of estimating prevalence of childhood cancer survivors (POCCS): example of the 20-year prevalence in The Netherlands. International Journal of Epidemiology. 52(6): 1898-1906. https://doi.org/10.1093/ije/dyad124 PMID:37738448
  71. Ginsburg O, Vanderpuye V, Beddoe AM, Bhoo-Pathy N, Bray F, Caduff C, et al. (2023). Women, power, and cancer: a Lancet Commission. Lancet. 402(10417): 2113-2166. https://doi.org/10.1016/S0140-6736(23)01701-4 PMID:37774725
  72. Gizaw M, Parkin DM, Stoter O, Korir A, Kamate B, Liu B, et al. (2023). Trends in the incidence of ovarian cancer in sub-Saharan Africa. International Journal of Cancer. 152(7): 1328-1336. https://doi.org/10.1002/ijc.34335 PMID:36274630
  73. Guimaraes Ribeiro A, Ferlay J, Piñeros M, Dias de Oliveira Latorre MdR, Tavares Guerreiro Fregnani JH, Bray F (2023). Geographic variations in cancer incidence and mortality in the State of São Paulo, Brazil 2001–17. Cancer Epidemiology. 85: 102403. https://doi.org/10.1016/j.canep.2023.102403 PMID:37390700
  74. Hammerl L, Mezger NCS, Seraphin TP, Joko-Fru WY, Griesel M, Feuchtner J, et al. (2023). Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study. Journal of the National Comprehensive Cancer Network. 21(9): 924-933 e927. https://doi.org/10.6004/jnccn.2023.7041 PMID:37673109
  75. Hanly P, Ortega MO, Pearce A, Cancela MD, Soerjomataram I, Sharp L (2023). Estimating Global Friction Periods for Economic Evaluation: A Case Study of Selected OECD Member Countries. Pharmacoeconomics. 41(9): 1093-1101. https://doi.org/10.1007/s40273-023-01261-y PMID:37036642
  76. Jubber I, Ong S, Bukavina L, Black PC, Comperat E, Kamat AM, et al. (2023). Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. European Urology. 84(2): 176-190. https://doi.org/10.1016/j.eururo.2023.03.029 PMID:37198015
  77. Kidayi PL, Pakpour AH, Saboonchi F, Bray F, Manhica H, Mtuya CC, et al. (2023). Cross-Cultural Adaptation and Psychometric Properties of the Swahili Version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-BR45 among Breast Cancer Patients in Tanzania. Healthcare (Basel). 11(18): 15. https://doi.org/10.3390/healthcare11182467 PMID:37761665
  78. Kiss Z, Kocsis J, Nikolenyi A, Horvath Z, Knollmajer K, Benedek A, et al. (2023). Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020. Frontiers in Oncology. 13: 1182170. https://doi.org/10.3389/fonc.2023.1182170 PMID:37795445
  79. Laronningen S, Skog A, Engholm G, Ferlay J, Johannesen TB, Kristiansen MF, et al. (2023). Nordcan.R: a new tool for federated analysis and quality assurance of cancer registry data. Frontiers in Oncology. 13: 1098342. https://doi.org/10.3389/fonc.2023.1098342 PMID:37614501
  80. Li M, Meheus F, Polazzi S, Delafosse P, Borson-Chazot F, Seigneurin A, et al. (2023). The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases. Value in Health. 26(8): 1175-1182. https://doi.org/10.1016/j.jval.2023.02.016 PMID:36921898
  81. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID:36241389
  82. Liu B, Abraham N, Chitsike I, Sylvie CGL, Kambugu J, Stevy NMA, et al. (2023). Enhancing information on stage at diagnosis for childhood cancer in Africa. Pediatric Blood & Cancer. 70(10): e30555. https://doi.org/10.1002/pbc.30555 PMID:37432023
  83. Luo G, Zhang Y, Etxeberria J, Arnold M, Cai X, Hao Y, et al. (2023). Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study. JMIR Public Health Surveill. 9(1): e43651. https://doi.org/10.2196/43651 PMID:36800235
  84. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers and Prevention. 32(1): 132-140. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID:36306379
  85. Mafra A, Bardot A, Charvat H, Weiderpass E, Soerjomataram I, Fregnani J (2023). Cancer survival in the northwestern of Sao Paulo State, Brazil: A population-based study. Cancer Epidemiology. 83: 102339. https://doi.org/10.1016/j.canep.2023.102339 PMID:36863216
  86. Mallon B, Kabore R, Couitchere L, Akonde FB, Narison MLR, Budiongo A, et al. (2023). The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group. Pediatric Blood & Cancer. 70(12): e30664. https://doi.org/10.1002/pbc.30664 PMID:37732944
  87. Marant Micallef C, Charvat H, Houot MT, Vignat J, Straif K, Paul A, et al. (2023). Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimates. Journal of Exposure Science & Environmental Epidemiology. 33(1): 125-131. https://doi.org/10.1038/s41370-021-00353-1 PMID:34172838
  88. Mohar A, Paredes A, Brau-Figueroa H, Sanchez A, Palafox A, Rivera-Gomez R, et al. (2023). [Not Available]. Salud Publica de México. 66(1, ene-feb): 104-112. https://doi.org/10.21149/15258 PMID:38065103
  89. Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. (2023). Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 72(2): 338-344. https://doi.org/10.1136/gutjnl-2022-327736 PMID:36604116
  90. Morgan E, O’Neill C, Bardot A, Walsh P, Soerjomataram I, Arnold M (2023). The Challenges of Collecting Long-Term Outcomes in Cancer Patients on the Population-Level: The Case of Metastatic Breast Cancer. J Registry Manag. 50(4): 173-175. PMID:38504704
  91. Myklebust TA, Aagnes B, Nilssen Y, Rutherford M, Lambert PC, Andersson TML, et al. (2023). Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications. British Journal of Cancer. 129(5): 819-828. https://doi.org/10.1038/s41416-023-02360-5 PMID:37433898
  92. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2023). Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018-2040. Appl Health Econ Health Policy. 21(6): 877-889. https://doi.org/10.1007/s40258-023-00824-6 PMID:37552416
  93. Parkin DM, Liu B, Adoubi I, Makouanzi AS, Masalu N, Mrema C, et al. (2023). Enhancing information on stage at diagnosis of cancer in Africa. Acta Oncologica. 62(4): 335-341. https://doi.org/10.1080/0284186X.2023.2205548 PMID:37102435
  94. Pineros M, Brierley J, Barrios E, Cueva P, Musetti C, Pardo C, et al. (2023). Accuracy of Essential TNM to stage large colorectal (T3/T4) cancers in absence of nodal status information. Acta Oncologica. 62(12): 1669-1671. https://doi.org/10.1080/0284186X.2023.2257376 PMID:37738263
  95. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F (2023). Thyroid Cancer Incidence and Mortality by Socioeconomic Level in the State of São Paulo, Brazil 2001-2017. Endocrine Practice. 29(10): 770-778. https://doi.org/10.1016/j.eprac.2023.07.028 PMID:37536501
  96. Ribeiro AG, Ferlay J, Vaccarella S, Latorre M, Fregnani J, Bray F (2023). Cancer inequalities in incidence and mortality in the State of Sao Paulo, Brazil 2001-17. Cancer Med. 12(15): 16615-16625. https://doi.org/10.1002/cam4.6259 PMID:37345901
  97. Ritter J, Allen S, Cohen PD, Fajardo AF, Marx K, Loggetto P, et al. (2023). Financial hardship in families of children or adolescents with cancer: a systematic literature review. Lancet Oncology. 24(9): e364-e375. https://doi.org/10.1016/S1470-2045(23)00320-0 PMID:37657477
  98. Roshandel G, Badar F, Barchuk A, Roder DM, Sangrajrang S, Mery L, et al. (2023). REPCAN: Guideline for REporting Population-based CANcer Registry Data. Asian Pacific Journal of Cancer Prevention. 24(9): 3297-3303. https://doi.org/10.31557/APJCP.2023.24.9.3297 PMID:37777857
  99. Rumgay H, Cabasag CJ, Offman J, de Camargo Cancela M, Barchuk A, Mathur P, et al. (2023). International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States. EClinicalMedicine. 66: 102289. https://doi.org/10.1016/j.eclinm.2023.102289 PMID:38192589
  100. Rumgay H, Ortega-Ortega M, Sharp L, Lunet N, Soerjomataram I (2023). The cost of premature death from cancer attributable to alcohol: Productivity losses in Europe in 2018. Cancer Epidemiology. 84: 102365. https://doi.org/10.1016/j.canep.2023.102365 PMID:37058915
  101. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, et al. (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17: 1553. https://doi.org/10.3332/ecancer.2023.1553 PMID:37377679
  102. Schmutz A, Matta M, Cairat M, Espina C, Schuz J, Kampman E, et al. (2023). Mapping the European cancer prevention research landscape: A case for more prevention research funding. European Journal of Cancer. 195: 113378. https://doi.org/10.1016/j.ejca.2023.113378 PMID:37924646
  103. Schuz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiology. 86 Suppl 1: 102453. https://doi.org/10.1016/j.canep.2023.102453 PMID:37852730
  104. Schuz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, et al. (2023). Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environmental Health: A Global Access Science Source. 22(1): 13. https://doi.org/10.1186/s12940-022-00952-x PMID:36703177
  105. Sedeta E, Sung H, Laversanne M, Bray F, Jemal A (2023). Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide. Cancer Epidemiology, Biomarkers and Prevention. 32(7): 894-905. https://doi.org/10.1158/1055-9965.EPI-22-1133 PMID:37195435
  106. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID:36528031
  107. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia MM, Miranda-Filho A, Ferlay J, et al. (2023). Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24(1): 22-32. https://doi.org/10.1016/S1470-2045(22)00704-5 PMID:36603919
  108. Song CV, van Gils CH, Yip CH, Soerjomataram I, Taib NAM, See MH, et al. (2023). Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting. Diagnostics (Basel). 13(4): 674. https://doi.org/10.3390/diagnostics13040674 PMID:36832162
  109. Storm HH, Laronningen S, Bray F (2023). Do investments in cancer registry databases and tools bring added value? NORDCAN as an example. Acta Oncologica. 62(6): 535-540. https://doi.org/10.1080/0284186X.2023.2218557 PMID:37276272
  110. Vaccarella S, Georges D, Bray F, Ginsburg O, Charvat H, Martikainen P, et al. (2023). Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study. Lancet Reg Health Eur. 25: 100551. https://doi.org/10.1016/j.lanepe.2022.100551 PMID:36818237
  111. Weber A, Laversanne M, Nagy P, Kenessey I, Soerjomataram I, Bray F (2023). Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 European countries 1995-2019. European Journal of Epidemiology. 38(11): 1141-1152. https://doi.org/10.1007/s10654-023-01039-8 PMID:37676425
  112. Weber A, Mery L, Nagy P, Polgar C, Bray F, Kenessey I (2023). Evaluation of data quality at the Hungarian National Cancer Registry, 2000-2019. Cancer Epidemiology. 82: 102306. https://doi.org/10.1016/j.canep.2022.102306 PMID:36521336
  113. Weber A, Morgan E, Vignat J, Laversanne M, Pizzato M, Rumgay H, et al. (2023). Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 13(5): e065303. https://doi.org/10.1136/bmjopen-2022-065303 PMID:37164477
  114. Wu L, Vaccarella S, Feng CY, Dal Maso L, Chen Y, Liu WW, et al. (2023). Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. Eur Thyroid J. 12(6): e230127. https://doi.org/10.1530/ETJ-23-0127 PMID:37855414
  115. Xu J, Xu W, Choi J, Brhane Y, Christiani DC, Kothari J, et al. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. Plos Genetics. 19(9): e1010902. https://doi.org/10.1371/journal.pgen.1010902 PMID:37738239
  116. Youlden DR, Steliarova-Foucher E, Gini A, Silva NP, Aitken JFJ (2023). The growing prevalence of childhood cancer survivors in Australia. Pediatric Blood & Cancer. 70(7): e30383. https://doi.org/10.1002/pbc.30383 PMID:37092826
  117. Zhang Y, Rumgay H, Li M, Cao S, Chen W (2023). Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health Surveill. 9: e49968. https://doi.org/10.2196/49968 PMID:37728964
  118. Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J (2023). The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 13: 04109. https://doi.org/10.7189/jogh.13.04109 PMID:37712386
  119. Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, et al. (2023). Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncology. 24(11): 1206-1218. https://doi.org/10.1016/S1470-2045(23)00444-8 PMID:37837979
  120. Zheng R, Wang S, Zhang S, Zeng H, Chen R, Sun K, et al. (2023). Global, regional, and national lifetime probabilities of developing cancer in 2020. Sci Bull (Beijing). 68(21): 2620-2628. https://doi.org/10.1016/j.scib.2023.09.041 PMID:37821267
  121. Znaor A, Ryzhov A, Losada ML, Carvalho A, Smelov V, Barchuk A, et al. (2023). Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 38: 100436. https://doi.org/10.1016/j.jcpo.2023.100436 PMID:37544479
  122. Zumsteg ZS, Luu M, Rosenberg PS, Elrod JK, Bray F, Vaccarella S, et al. (2023). Global epidemiologic patterns of oropharyngeal cancer incidence trends. Journal of the National Cancer Institute. 115(12): 1544-1554. https://doi.org/10.1093/jnci/djad169 PMID:37603716
  123. Alkhalawi E, Znaor A, Al-Zahrani AS (2022). Quality of data from cancer registries in the Eastern Mediterranean region. Lancet Oncology. 23(4): 449-451. https://doi.org/10.1016/S1470-2045(22)00072-9 PMID:35358450
  124. Andersson TM, Myklebust TA, Rutherford MJ, Moller B, Arnold M, Soerjomataram I, et al. (2022). Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2. British Journal of Cancer. 126(8): 1224-1228. https://doi.org/10.1038/s41416-022-01701-0 PMID:35058590
  125. Andersson TM, Rutherford MJ, Myklebust TA, Moller B, Arnold M, Soerjomataram I, et al. (2022). A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2. Cancer Epidemiology. 76: 102085. https://doi.org/10.1016/j.canep.2021.102085 PMID:34954495
  126. Araghi M, Fidler-Benaoudia M, Arnold M, Rutherford M, Bardot A, Ferlay J, et al. (2022). International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study. Thorax. 77(4): 378-390. https://doi.org/10.1136/thoraxjnl-2020-216555 PMID:34282033
  127. Arnold M, Morgan E, Bardot A, Rutherford MJ, Ferlay J, Little A, et al. (2022). International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut. 71(8): 1532-1543. https://doi.org/10.1136/gutjnl-2021-325266 PMID:34824149
  128. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 66: 15-23. https://doi.org/10.1016/j.breast.2022.08.010 PMID:36084384
  129. Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. (2022). Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol. 158(5): 495-503. https://doi.org/10.1001/jamadermatol.2022.0160 PMID:35353115
  130. Banack HR, Chang J, Stefanick ML, Arnold M, Anton-Culver H, Jiang L (2022). Relationship between BMI trajectories and cardiometabolic outcomes in postmenopausal women: a growth mixture modeling approach. Annals of Epidemiology. 72: 9-17. https://doi.org/10.1016/j.annepidem.2022.04.004 PMID:35469929
  131. Bravo LE, Garcia LS, Collazos P, Holguin J, Soerjomataram I, Miranda-Filho A (2022). Trends in long-term cancer survival in Cali, Colombia: 1998-2017. Colomb Med (Cali). 53(1): e2035082. https://doi.org/10.25100/cm.v53i1.5082 PMID:36452118
  132. Bray F, Parkin DM, African Cancer Registry N (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 23(6): 719-728. https://doi.org/10.1016/S1470-2045(22)00270-4 PMID:35550275
  133. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. European Urology. 82(5): 529-542. https://doi.org/10.1016/j.eururo.2022.08.019 PMID:36100483
  134. Byrne J, Schmidtmann I, Rashid H, Hagberg O, Bagnasco F, Bardi E, et al. (2022). Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. International Journal of Cancer. 150(3): 406-419. https://doi.org/10.1002/ijc.33817 PMID:34551126
  135. Cabasag CJ, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E, et al. (2022). Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. British Journal of Cancer. 126(12): 1774-1782. https://doi.org/10.1038/s41416-022-01752-3 PMID:35236937
  136. Cabasag CJ, Fagan PJ, Ferlay J, Vignat J, Laversanne M, Liu L, et al. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. International Journal of Cancer. 151(9): 1535-1541. https://doi.org/10.1002/ijc.34002 PMID:35322413
  137. Cabasag CJ, Ferlay J, Laversanne M, Vignat J, Weber A, Soerjomataram I, et al. (2022). Pancreatic cancer: an increasing global public health concern. Gut. 71(8): 1686-1687. https://doi.org/10.1136/gutjnl-2021-326311 PMID:34686577
  138. Cabasag CJ, Vignat J, Ferlay J, Arndt V, Lemmens V, Praagman J, et al. (2022). The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. European Journal of Cancer. 177: 15-24. https://doi.org/10.1016/j.ejca.2022.09.030 PMID:36323048
  139. Carle C, Hughes S, Freeman V, Campbell D, Egger S, Caruana M, et al. (2022). The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. J Cancer Policy. 33: 100338. https://doi.org/10.1016/j.jcpo.2022.100338 PMID:35671919
  140. Chargari C, Arbyn M, Leary A, Abu-Rustum NR, Basu P, Bray F, et al. (2022). Increasing global accessibility to high-level treatments for cervical cancers. Gynecologic Oncology. 164(1): 231-241. https://doi.org/10.1016/j.ygyno.2021.10.073 PMID:34716024
  141. Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, et al. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiology, Biomarkers and Prevention. 31(2): 325-333. https://doi.org/10.1158/1055-9965.EPI-21-0688 PMID:34782393
  142. De Camargo Cancela M, Bezerra de Souza DL, Leite Martins LF, Borges L, Schilithz AO, Hanly P, et al. (2022). Can the sustainable development goals for cancer be met in Brazil? A population-based study. Frontiers in Oncology. 12: 1060608. https://doi.org/10.3389/fonc.2022.1060608 PMID:36703792
  143. de Camargo Cancela M, de Oliveira Santos M, Migowski A, Pineros M (2022). Breast cancer among young women in Brazil: Differences between hospital and population-based series. Cancer Epidemiology. 79: 102193. https://doi.org/10.1016/j.canep.2022.102193 PMID:35696767
  144. Dee EC, Eala MAB, Chua MLK, Bray F, Bhoo-Pathy N (2022). Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective. Pediatric Blood & Cancer. 69(7): e29593. https://doi.org/10.1002/pbc.29593 PMID:35129873
  145. Dee EC, Santos PMG, Bray F (2022). The shifting epidemiology of lung cancer in Asian and Asian diaspora populations: Implications for clinical and global health policy research. Asia-Pacific Journal of Clinical Oncology. 18(5): e524-e525. https://doi.org/10.1111/ajco.13738 PMID:35098661
  146. Doganis D, Karalexi MA, group N-Sc, Panagopoulou P, Bouka P, Bouka E, et al. (2022). Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA. Cancer Epidemiology. 78: 102153. https://doi.org/10.1016/j.canep.2022.102153 PMID:35390585
  147. Freeman V, Hughes S, Carle C, Campbell D, Egger S, Hui H, et al. (2022). Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy. 33: 100340. https://doi.org/10.1016/j.jcpo.2022.100340 PMID:35680113
  148. Gil F, Miranda-Filho A, Uribe-Perez C, Arias-Ortiz NE, Yepez-Chamorro MC, Bravo LM, et al. (2022). Impact of the Management and Proportion of Lost to Follow-Up Cases on Cancer Survival Estimates for Small Population-Based Cancer Registries. Journal of Cancer Epidemiology. 2022: 9068214. https://doi.org/10.1155/2022/9068214 PMID:35140789
  149. Gini A, Selby K (2022). Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population? Clinical Gastroenterology and Hepatology. 20(10): 2216-2217. https://doi.org/10.1016/j.cgh.2022.03.030 PMID:35390510
  150. Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, et al. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine. 28(12): 2563-2572. https://doi.org/10.1038/s41591-022-02109-2 PMID:36404355
  151. Hanly P, Ortega-Ortega M, Soerjomataram I (2022). Cancer Premature Mortality Costs in Europe in 2020: A Comparison of the Human Capital Approach and the Friction Cost Approach. Current Oncology (Toronto, Ont.). 29(5): 3552-3564. https://doi.org/10.3390/curroncol29050287 PMID:35621677
  152. Ibrahim Khalil A, Franceschi S, de Martel C, Bray F, Clifford GM (2022). Burden of Kaposi sarcoma according to HIV status: A systematic review and global analysis. International Journal of Cancer. 150(12): 1948-1957. https://doi.org/10.1002/ijc.33951 PMID:35085400
  153. Ibrahim Khalil A, Mpunga T, Wei F, Baussano I, de Martel C, Bray F, et al. (2022). Age-specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub-Saharan Africa. International Journal of Cancer. 150(5): 761-772. https://doi.org/10.1002/ijc.33841 PMID:34626498
  154. Ilbawi AM, Lam CG, Ortiz R, Bray F (2022). Investing in childhood cancer registries to drive progress. Lancet Child Adolesc Health. 6(7): 446-447. https://doi.org/10.1016/S2352-4642(22)00148-1 PMID:35605627
  155. Kenessey I, Szoke G, Dobozi M, Szatmari I, Weber A, Fogarassy G, et al. (2022). Comparison of Cancer Survival Trends in Hungary in the Periods 2001-2005 and 2011-2015 According to a Population-Based Cancer Registry. Pathology Oncology Research. 28: 1610668. https://doi.org/10.3389/pore.2022.1610668 PMID:36147657
  156. Kiss Z, Wittmann I, Polivka L, Surjan G, Surjan O, Barcza Z, et al. (2022). Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study). Frontiers in Immunology. 13: 905585. https://doi.org/10.3389/fimmu.2022.905585 PMID:35812442
  157. Kiss ZN, Bogos K, Tamasi L, Ostoros G, Muller V, Bittner N, et al. (2022). Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study). Frontiers in Oncology. 12: 1032366. https://doi.org/10.3389/fonc.2022.1032366 PMID:36505881
  158. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. https://doi.org/10.1186/s12885-022-09589-y PMID:35568802
  159. Leal YA, Torres J, Gamboa R, Mantilla-Morales A, Pina-Sanchez P, Arrieta O, et al. (2022). Cancer Incidence in Merida, Mexico 2015-2018: First Report from the Population-based Cancer Registry. Archives of Medical Research. 53(8): 859-866. https://doi.org/10.1016/j.arcmed.2022.11.015 PMID:36462950
  160. Li M, Zhang L, Charvat H, Callister ME, Sasieni P, Christodoulou E, et al. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. International Journal of Cancer. 151(9): 1491-1501. https://doi.org/10.1002/ijc.34167 PMID:35809038
  161. Lorenzoni V, Chaturvedi AK, Vignat J, Laversanne M, Bray F, Vaccarella S (2022). The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020. Cancer Epidemiology, Biomarkers and Prevention. 31(11): 2054-2062. https://doi.org/10.1158/1055-9965.EPI-22-0642 PMID:36173880
  162. Luo Q, Lew JB, Steinberg J, Worthington J, Yu XQ, Caruana M, et al. (2022). Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040. Scientific Reports. 12(1): 3994. https://doi.org/10.1038/s41598-022-07797-x PMID:35256697
  163. Luo Q, O’Connell DL, Yu XQ, Kahn C, Caruana M, Pesola F, et al. (2022). Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. Lancet Public Health. 7(6): e537-e548. https://doi.org/10.1016/S2468-2667(22)00090-1 PMID:35660215
  164. Mafra A, Laversanne M, Gospodarowicz M, Klinger P, De Paula Silva N, Pineros M, et al. (2022). Global patterns of non-Hodgkin lymphoma in 2020. International Journal of Cancer. 151(9): 1474-1481. https://doi.org/10.1002/ijc.34163 PMID:35695282
  165. Mafra da Costa A, Hernandes ICP, Weiderpass E, Soerjomataram I, Fregnani J (2022). Cancer Statistics over Time in Northwestern Sao Paulo State, Brazil: Incidence and Mortality. Cancer Epidemiology, Biomarkers and Prevention. 31(4): 707-714. https://doi.org/10.1158/1055-9965.EPI-21-0842 PMID:35131883
  166. Malakova K, Cabasag CJ, Bardot A, Sangrajrang S, Chitapanarux I, Sripan P, et al. (2022). Cancer survival in Thailand from 1997 to 2012: Assessing the impact of universal health coverage. J Cancer Policy. 34: 100353. https://doi.org/10.1016/j.jcpo.2022.100353 PMID:36357312
  167. Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 47: 101404. https://doi.org/10.1016/j.eclinm.2022.101404 PMID:35497064
  168. Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. (2022). The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 163(3): 649-658 e642. https://doi.org/10.1053/j.gastro.2022.05.054 PMID:35671803
  169. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Mohebbi E, Ravankhah Z, et al. (2022). National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. International Journal of Cancer. 151(12): 2128-2135. https://doi.org/10.1002/ijc.34224 PMID:35869869
  170. Nemati S, Saeedi E, Roshandel G, Nahvijou A, Badakhshan A, Akbari M, et al. (2022). Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012. Cancer Epidemiology. 77: 102089. https://doi.org/10.1016/j.canep.2021.102089 PMID:35042146
  171. Noll F, Adams T, Cohen R, Soerjomataram I, Reid F (2022). Building opportunities to improve quality of life for women with ovarian cancer in low- and middle-income countries: the Every Woman Study. International Journal of Gynecological Cancer. 32(8): 1080-1081. https://doi.org/10.1136/ijgc-2022-003449 PMID:35314459
  172. Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L (2022). Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. International Journal of Cancer. 150(4): 580-593. https://doi.org/10.1002/ijc.33826 PMID:34569617
  173. Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, et al. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiology, Biomarkers and Prevention. 31(12): 2237-2243. https://doi.org/10.1158/1055-9965.EPI-22-0376 PMID:36126276
  174. Payne NWS, Brown KF, Delon C, Kotrotsios Y, Soerjomataram I, Shelton J (2022). Socio-economic deprivation and cancer incidence in England: Quantifying the role of smoking. PloS One. 17(9): e0272202. https://doi.org/10.1371/journal.pone.0272202 PMID:36129905
  175. Persson MSM, Yin W, Doring N, Risnes K, Weiderpass E, Steliarova-Foucher E, et al. (2022). Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study. International Journal of Cancer. 150(8): 1269-1280. https://doi.org/10.1002/ijc.33886 PMID:34855204
  176. Pierannunzio D, Fedeli U, Francisci S, Paoli A, Toffolutti F, Serraino D, et al. (2022). Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018. Thyroid. 32(3): 263-272. https://doi.org/10.1089/thy.2021.0531 PMID:35018816
  177. Pilleron S, Alqurini N, Ferlay J, Haase KR, Hannan M, Janssen-Heijnen M, et al. (2022). International trends in cancer incidence in middle-aged and older adults in 44 countries. Journal of Geriatric Oncology. 13(3): 346-355. https://doi.org/10.1016/j.jgo.2021.11.011 PMID:34866023
  178. Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, et al. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers. 14(6). https://doi.org/10.3390/cancers14061529 PMID:35326681
  179. Pineros M (2022). Evaluation and variability of quality in mortality statistics in Colombia: the importance of detail. REVISTA COLOMBIANA DE CANCEROLOGIA. 26(3): 241-243.
  180. Pineros M, Ginsburg O, Bendahhou K, Eser S, Shelpai WA, Fouad H, et al. (2022). Staging practices and breast cancer stage among population-based registries in the MENA region. Cancer Epidemiology. 81: 102250. https://doi.org/10.1016/j.canep.2022.102250 PMID:36115143
  181. Pineros M, Laversanne M, Barrios E, Cancela MC, de Vries E, Pardo C, et al. (2022). An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean. Lancet Reg Health Am. 13: None. https://doi.org/10.1016/j.lana.2022.100294 PMID:36189115
  182. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. (2022). The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes and Endocrinology. 10(4): 264-272. https://doi.org/10.1016/S2213-8587(22)00035-3 PMID:35271818
  183. Pizzato M, Martinsen JI, Heikkinen S, Vignat J, Lynge E, Sparen P, et al. (2022). Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries. Cancer Med. 11(8): 1850-1859. https://doi.org/10.1002/cam4.4548 PMID:35166068
  184. Roel E, Pistillo A, Recalde M, Fernandez-Bertolin S, Aragon M, Soerjomataram I, et al. (2022). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. International Journal of Cancer. 150(5): 782-794. https://doi.org/10.1002/ijc.33846 PMID:34655476
  185. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. (2022). Global burden of primary liver cancer in 2020 and predictions to 2040. Journal of Hepatology. 77(6): 1598-1606. https://doi.org/10.1016/j.jhep.2022.08.021 PMID:36208844
  186. Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. (2022). Global, regional and national burden of primary liver cancer by subtype. European Journal of Cancer. 161: 108-118. https://doi.org/10.1016/j.ejca.2021.11.023 PMID:34942552
  187. Sarich P, Cabasag CJ, Liebermann E, Vaneckova P, Carle C, Hughes S, et al. (2022). Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 47: 101375. https://doi.org/10.1016/j.eclinm.2022.101375 PMID:35434579
  188. Singh D, Vaccarella S, Gini A, De Paula Silva N, Steliarova-Foucher E, Bray F (2022). Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040. International Journal of Cancer. 150(12): 1941-1947. https://doi.org/10.1002/ijc.33948 PMID:35080783
  189. Smith L, Stiller CA, Aitken JF, Hjalgrim LL, Johannesen T, Lahteenmaki P, et al. (2022). International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries. International Journal of Cancer. 150(1): 28-37. https://doi.org/10.1002/ijc.33774 PMID:34449879
  190. Soerjomataram I, Bardot A, Aitken J, Pineros M, Znaor A, Steliarova-Foucher E, et al. (2022). Impact of the COVID-19 pandemic on population-based cancer registry. International Journal of Cancer. 150(2): 273-278. https://doi.org/10.1002/ijc.33792 PMID:34480348
  191. Soerjomataram I, Bray F, Lansdorp-Vogelaar I, Ginsburg O, Rahal R, Sullivan R, et al. (2022). COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies. J Cancer Policy. 32: 100328. https://doi.org/10.1016/j.jcpo.2022.100328 PMID:35560265
  192. Soo R, Mery L, Bardot A, Kanesvaran R, Keong TC, Pongnikorn D, et al. (2022). Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries. ESMO Open. 7(5): 100560. https://doi.org/10.1016/j.esmoop.2022.100560 PMID:35988454
  193. Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, et al. (2022). Global challenges and policy solutions in breast cancer control. Cancer Treatment Reviews. 104: 102339. https://doi.org/10.1016/j.ctrv.2022.102339 PMID:35074727
  194. Voko Z, Kiss Z, Surjan G, Surjan O, Barcza Z, Wittmann I, et al. (2022). Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study). Frontiers in Immunology. 13: 919408. https://doi.org/10.3389/fimmu.2022.919408 PMID:35935993
  195. Wang S, Zheng R, Arnold M, Abnet C, Zeng H, Zhang S, et al. (2022). Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype. International Journal of Cancer. 151(9): 1447-1461. https://doi.org/10.1002/ijc.34158 PMID:35678331
  196. Weber A, Szatmari I, Dobozi M, Hilbert L, Branyiczkine Geczy G, Nagy P, et al. (2022). [Comparison of Hungarian Central Statistical Office’s causes of death data with the database of the Hungarian National Cancer Registry]. Orvosi Hetilap. 163(37): 1481-1489. https://doi.org/10.1556/650.2022.32573 PMID:36088625
  197. Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S, Nicholson B, et al. (2022). Current and projected number of years of life lost due to prostate cancer: A global study. Prostate. 82(11): 1088-1097. https://doi.org/10.1002/pros.24360 PMID:35468227
  198. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2022). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tobacco Control. https://doi.org/10.1136/tc-2022-057262 PMID:36100264
  199. Znaor A, Corbex M, Cao B, Laversanne M, Ryzhov A, Smelov V, et al. (2022). Progress in reducing premature mortality from cancer and cardiovascular disease in the former Soviet Union, 2000-19. European Journal of Public Health. 32(4): 624-629. https://doi.org/10.1093/eurpub/ckac030 PMID:35441219
  200. Znaor A, Skakkebaek NE, Rajpert-De Meyts E, Kulis T, Laversanne M, Gurney J, et al. (2022). Global patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer. 151(5): 692-698. https://doi.org/10.1002/ijc.33999 PMID:35277970
  201. Amosa-Lei Sam F, Akinremi A, Mery L, Sarfati D, Stanley J, Gurney J (2021). Cancer Incidence in Samoa: A 10-Year Retrospective Survey (2007-2016). Asia-Pacific Journal of Public Health. 33(6-7): 700-706. https://doi.org/10.1177/1010539520975261 PMID:33233921
  202. Andersson TM, Myklebust TA, Rutherford MJ, Moller B, Soerjomataram I, Arnold M, et al. (2021). The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiology. 71(Pt A): 101881. https://doi.org/10.1016/j.canep.2020.101881 PMID:33440295
  203. Andersson TM, Rutherford MJ, Myklebust TA, Moller B, Soerjomataram I, Arnold M, et al. (2021). Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. British Journal of Cancer. 124(5): 1026-1032. https://doi.org/10.1038/s41416-020-01196-7 PMID:33293692
  204. Araghi M, Arnold M, Rutherford MJ, Guren MG, Cabasag CJ, Bardot A, et al. (2021). Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 70(1): 114-126. https://doi.org/10.1136/gutjnl-2020-320625 PMID:32482683
  205. Arbyn M, Gultekin M, Morice P, Nieminen P, Cruickshank M, Poortmans P, et al. (2021). The European response to the WHO call to eliminate cervical cancer as a public health problem. International Journal of Cancer. 148(2): 277-284. https://doi.org/10.1002/ijc.33189 PMID:32638362
  206. Barchuk A, Belyaev A, Gretsova O, Tursun-Zade R, Moshina N, Znaor A (2021). History and current status of cancer registration in Russia. Cancer Epidemiology. 73: 101963. https://doi.org/10.1016/j.canep.2021.101963 PMID:34089992
  207. Barchuk A, Tursun-Zade R, Belayev A, Moore M, Komarov Y, Moshina N, et al. (2021). Comparability and validity of cancer registry data in the northwest of Russia. Acta Oncologica. 60(10): 1264-1271. https://doi.org/10.1080/0284186X.2021.1967443 PMID:34424113
  208. Bonjour M, Charvat H, Franco EL, Pineros M, Clifford GM, Bray F, et al. (2021). Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 6(7): e510-e521. https://doi.org/10.1016/S2468-2667(21)00046-3 PMID:33864738
  209. Bray F, Laversanne M, Cao B, Varghese C, Mikkelsen B, Weiderpass E, et al. (2021). Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4. Cancer Treatment Reviews. 100: 102290. https://doi.org/10.1016/j.ctrv.2021.102290 PMID:34536729
  210. Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021). The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127(16): 3029-3030. https://doi.org/10.1002/cncr.33587 PMID:34086348
  211. Bukirwa P, Wabinga H, Nambooze S, Amulen PM, Joko WY, Liu B, et al. (2021). Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. International Journal of Cancer. 148(9): 2129-2138. https://doi.org/10.1002/ijc.33373 PMID:33129228
  212. Cabasag CJ, Arnold M, Pineros M, Morgan E, Brierley J, Hofferkamp J, et al. (2021). Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2. International Journal of Cancer. 149(6): 1239-1246. https://doi.org/10.1002/ijc.33679 PMID:33990959
  213. Conway DI, Hovanec J, Ahrens W, Ross A, Holcatova I, Lagiou P, et al. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. Journal of Epidemiology and Community Health. 75(8): 779-787. https://doi.org/10.1136/jech-2020-214913 PMID:33622804
  214. Crocetti E, Mattioli V, Buzzoni C, Franceschi S, Serraino D, Vaccarella S, et al. (2021). Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012. Cancer Med. 10(19): 6855-6867. https://doi.org/10.1002/cam4.4193 PMID:34533289
  215. Dal Maso L, Panato C, De Paoli A, Mattioli V, Serraino D, Elisei R, et al. (2021). Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy. Journal of Endocrinological Investigation. 44(8): 1679-1688. https://doi.org/10.1007/s40618-020-01475-3 PMID:33460012
  216. Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, et al. (2021). National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncology. 22(11): 1632-1642. https://doi.org/10.1016/S1470-2045(21)00462-9 PMID:34653370
  217. Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. (2021). The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. European Journal of Cancer. 157: 308-347. https://doi.org/10.1016/j.ejca.2021.07.039 PMID:34560371
  218. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pineros M, Znaor A, et al. (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer. 149(4): 778-789. https://doi.org/10.1002/ijc.33588 PMID:33818764
  219. Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. (2021). Epidemiology and Prevention of Prostate Cancer. Eur Urol Oncol. 4(6): 877-892. https://doi.org/10.1016/j.euo.2021.09.006 PMID:34716119
  220. Genere N, El Kawkgi OM, Giblon RE, Vaccarella S, Morris JC, Hay ID, et al. (2021). Incidence of Clinically Relevant Thyroid Cancers Remains Stable for Almost a Century: A Population-Based Study. Mayo Clinic Proceedings. 96(11): 2823-2830. https://doi.org/10.1016/j.mayocp.2021.04.028 PMID:34736609
  221. Gredner T, Mons U, Niedermaier T, Brenner H, Soerjomataram I (2021). Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study. Lancet Reg Health Eur. 4: 100074. https://doi.org/10.1016/j.lanepe.2021.100074 PMID:34029359
  222. Gullickson C, Goodman M, Joko-Fru YW, Gnangnon FHR, N’Da G, Woldegeorgis MA, et al. (2021). Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. International Journal of Cancer. 149(8): 1553-1563. https://doi.org/10.1002/ijc.33715 PMID:34164808
  223. Johnson S, Tittenbrun Z, Romero Y, Torode J, Frech S, Abdel-Wahab M, et al. (2021). The World Cancer Declaration: time to consolidate wins and work towards 2025. Lancet Oncology. 22(3): 296-298. https://doi.org/10.1016/S1470-2045(21)00012-7 PMID:33548178
  224. Johnston WT, Erdmann F, Newton R, Steliarova-Foucher E, Schuz J, Roman E (2021). Childhood cancer: Estimating regional and global incidence. Cancer Epidemiology. 71(Pt B): 101662. https://doi.org/10.1016/j.canep.2019.101662 PMID:31924557
  225. Kilian C, Rovira P, Neufeld M, Ferreira-Borges C, Rumgay H, Soerjomataram I, et al. (2021). Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region. Lancet Reg Health Eur. 11: 100225. https://doi.org/10.1016/j.lanepe.2021.100225 PMID:34918000
  226. Li M, Delafosse P, Meheus F, Borson-Chazot F, Lifante JC, Simon R, et al. (2021). Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986-2015: The impact of overdiagnosis. Cancer Epidemiology. 75: 102051. https://doi.org/10.1016/j.canep.2021.102051 PMID:34743057
  227. Li M, Zheng R, Dal Maso L, Zhang S, Wei W, Vaccarella S (2021). Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes and Endocrinology. 9(6): 330-332. https://doi.org/10.1016/S2213-8587(21)00083-8 PMID:33891886
  228. Liu B, Youlden DR, Wabinga H, Nambooze S, Amulen PM, Aitken JF, et al. (2021). Survival from childhood cancer in Kampala, Uganda. Pediatric Blood & Cancer. 68(3): e28876. https://doi.org/10.1002/pbc.28876 PMID:33381877
  229. Longatto-Filho A, Fregnani JH, Mafra da Costa A, de Araujo-Souza PS, Scapulatempo-Neto C, Herbster S, et al. (2021). Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity. Acta Cytologica. 65(2): 165-174. https://doi.org/10.1159/000512010 PMID:33271565
  230. Mafra da Costa A, Ribeiro AL, Ribeiro AG, Gini A, Cabasag C, Reis RM, et al. (2021). Impact of COVID-19 Pandemic on Cancer-Related Hospitalizations in Brazil. Cancer Control. 28: 10732748211038736. https://doi.org/10.1177/10732748211038736 PMID:34406894
  231. Mandrik O, Tolma E, Zielonke N, Meheus F, Ordonez-Reyes C, Severens JL, et al. (2021). Systematic reviews as a “lens of evidence”: Determinants of participation in breast cancer screening. Journal of Medical Screening. 28(2): 70-79. https://doi.org/10.1177/0969141320930743 PMID:32517538
  232. Marant Micallef C, Paul A, Charvat H, Vignat J, Houot M, Pilorget C, et al. (2021). An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France. Journal of Exposure Science & Environmental Epidemiology. 31(4): 769-776. https://doi.org/10.1038/s41370-020-00272-7 PMID:33144638
  233. Miranda-Filho A, Charvat H, Bray F, Migowski A, Cheung LC, Vaccarella S, et al. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. https://doi.org/10.1016/j.eclinm.2021.101176 PMID:34765952
  234. Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. (2021). Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes and Endocrinology. 9(4): 225-234. https://doi.org/10.1016/S2213-8587(21)00027-9 PMID:33662333
  235. Morgan E, Arnold M, Rutherford MJ, Bardot A, Ferlay J, De P, et al. (2021). The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project). International Journal of Cancer. 149(5): 1013-1020. https://doi.org/10.1002/ijc.33620 PMID:33932300
  236. Morgan E, Soerjomataram I, Gavin AT, Rutherford MJ, Gatenby P, Bardot A, et al. (2021). International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 70(2): 234-242. https://doi.org/10.1136/gutjnl-2020-321089 PMID:32554620
  237. Musetti C, Garau M, Alonso R, Pineros M, Soerjomataram I, Barrios E (2021). Colorectal Cancer in Young and Older Adults in Uruguay: Changes in Recent Incidence and Mortality Trends. International Journal of Environmental Research and Public Health. 18(15): 8232. https://doi.org/10.3390/ijerph18158232 PMID:34360522
  238. Parkin DM, Chingonzoh T, Vuma S, Liu B, Chokunonga E, Ndlovu N, et al. (2021). Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiology, Biomarkers and Prevention. 30(5): 867-873. https://doi.org/10.1158/1055-9965.EPI-20-0669 PMID:33619023
  239. Parkin DM, Youlden DR, Chitsike I, Chokunonga E, Couitchere L, Gnahatin F, et al. (2021). Stage at diagnosis and survival by stage for the leading childhood cancers in three populations of sub-Saharan Africa. International Journal of Cancer. 148(11): 2685-2691. https://doi.org/10.1002/ijc.33468 PMID:33433927
  240. Perera SK, Jacob S, Wilson BE, Ferlay J, Bray F, Sullivan R, et al. (2021). Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study. Lancet Oncology. 22(2): 182-189. https://doi.org/10.1016/S1470-2045(20)30675-6 PMID:33485458
  241. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, et al. (2021). Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. International Journal of Cancer. 148(7): 1575-1585. https://doi.org/10.1002/ijc.33326 PMID:33006395
  242. Pilleron S, Maringe C, Charvat H, Atkinson J, Morris E, Sarfati D (2021). Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung Cancer. 157: 92-99. https://doi.org/10.1016/j.lungcan.2021.05.015 PMID:34006378
  243. Pilleron S, Maringe C, Charvat H, Atkinson J, Morris EJA, Sarfati D (2021). The impact of timely cancer diagnosis on age disparities in colon cancer survival. Journal of Geriatric Oncology. 12(7): 1044-1051. https://doi.org/10.1016/j.jgo.2021.04.003 PMID:33863698
  244. Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F, et al. (2021). Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. International Journal of Cancer. 148(3): 601-608. https://doi.org/10.1002/ijc.33232 PMID:32706917
  245. Pineros M, Abriata MG, de Vries E, Barrios E, Bravo LE, Cueva P, et al. (2021). Progress, challenges and ways forward supporting cancer surveillance in Latin America. International Journal of Cancer. 149(1): 12-20. https://doi.org/10.1002/ijc.33407 PMID:33231289
  246. Pineros M, Mery L, Soerjomataram I, Bray F, Steliarova-Foucher E (2021). Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap. Journal of the National Cancer Institute. 113(1): 9-15. https://doi.org/10.1093/jnci/djaa069 PMID:32433739
  247. Pineros M, Saraiya M, Baussano I, Bonjour M, Chao A, Bray F (2021). The role and utility of population-based cancer registries in cervical cancer surveillance and control. Preventive Medicine. 144: 106237. https://doi.org/10.1016/j.ypmed.2020.106237 PMID:33678223
  248. Puyol M, Seoane J, Aguilar E, Vozza LB, Orbe I, Crawford KH, et al. (2021). WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer. Clinical Cancer Research. 27(4): 963-966. https://doi.org/10.1158/1078-0432.CCR-20-2978 PMID:33257425
  249. Roel E, Pistillo A, Recalde M, Sena AG, Fernandez-Bertolin S, Aragon M, et al. (2021). Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiology, Biomarkers and Prevention. 30(10): 1884-1894. https://doi.org/10.1158/1055-9965.EPI-21-0266 PMID:34272262
  250. Roshandel G, Ferlay J, Ghanbari-Motlagh A, Partovipour E, Salavati F, Aryan K, et al. (2021). Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. 149(3): 594-605. https://doi.org/10.1002/ijc.33574 PMID:33884608
  251. Rovira P, Kilian C, Neufeld M, Rumgay H, Soerjomataram I, Ferreira-Borges C, et al. (2021). Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study. European Addiction Research. 27(3): 189-197. https://doi.org/10.1159/000511899 PMID:33271557
  252. Rumgay H, Arnold M, Laversanne M, Whiteman DC, Thrift AP, Wei W, et al. (2021). International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. American Journal of Gastroenterology. 116(5): 1072-1076. https://doi.org/10.14309/ajg.0000000000001121 PMID:33929382
  253. Rumgay H, Murphy N, Ferrari P, Soerjomataram I (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 13(9). https://doi.org/10.3390/nu13093173 PMID:34579050
  254. Rumgay H, Shield K, Charvat H, Ferrari P, Sornpaisarn B, Obot I, et al. (2021). Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncology. 22(8): 1071-1080. https://doi.org/10.1016/S1470-2045(21)00279-5 PMID:34270924
  255. Rutherford MJ, Arnold M, Bardot A, Ferlay J, De P, Tervonen H, et al. (2021). Comparison of liver cancer incidence and survival by subtypes across seven high-income countries. International Journal of Cancer. 149(12): 2020-2031. https://doi.org/10.1002/ijc.33767 PMID:34460109
  256. Ryzhov A, Corbex M, Pineros M, Barchuk A, Andreasyan D, Djanklich S, et al. (2021). Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncology. 22(3): 361-369. https://doi.org/10.1016/S1470-2045(20)30674-4 PMID:33556324
  257. Salamat F, Aryannia A, Rajaei S, Naeimi-Tabiei M, Afghani R, Sedaghat SM, et al. (2021). Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013. Archives of Iranian Medicine. 24(1): 1-6. https://doi.org/10.34172/aim.2021.01 PMID:33588561
  258. Seraphin TP, Joko-Fru WY, Hammerl L, Griesel M, Mezger NCS, Feuchtner JC, et al. (2021). Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 127(22): 4221-4232. https://doi.org/10.1002/cncr.33818 PMID:34328216
  259. Seraphin TP, Joko-Fru WY, Kamate B, Chokunonga E, Wabinga H, Somdyala NIM, et al. (2021). Rising Prostate Cancer Incidence in Sub-Saharan Africa: A Trend Analysis of Data from the African Cancer Registry Network. Cancer Epidemiology, Biomarkers and Prevention. 30(1): 158-165. https://doi.org/10.1158/1055-9965.EPI-20-1005 PMID:33033143
  260. Seraphin TP, Joko-Fru WY, Manraj SS, Chokunonga E, Somdyala NIM, Korir A, et al. (2021). Prostate cancer survival in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study. Cancer Causes and Control. 32(9): 1001-1019. https://doi.org/10.1007/s10552-021-01453-x PMID:34244896
  261. Snijders R, Fukinsia A, Claeys Y, Hasker E, Mpanya A, Miaka E, et al. (2021). Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo. Emerging Infectious Diseases. 27(8): 2144-2153. https://doi.org/10.3201/eid2708.202399 PMID:34287133
  262. Soerjomataram I, Bray F (2021). Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nature Reviews: Clinical Oncology. 18(10): 663-672. https://doi.org/10.1038/s41571-021-00514-z PMID:34079102
  263. Soerjomataram I, Ervik M, Fox C, Hawkins S, Yeung K, Napolitano G, et al. (2021). CanStaging+: an electronic staging tool for population-based cancer registries. Lancet Oncology. 22(8): 1069. https://doi.org/10.1016/S1470-2045(21)00188-1 PMID:34339643
  264. Stoeter O, Seraphin TP, Chitsike I, Chokunonga E, Kambugu JB, Wabinga H, et al. (2021). Trends in childhood cancer incidence in sub-Saharan Africa: Results from 25 years of cancer registration in Harare (Zimbabwe) and Kyadondo (Uganda). International Journal of Cancer. 149(5): 1002-1012. https://doi.org/10.1002/ijc.33619 PMID:33945631
  265. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 71(3): 209-249. https://doi.org/10.3322/caac.21660 PMID:33538338
  266. Vaccarella S, Dal Maso L (2021). Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes and Endocrinology. 9(2): 57-59. https://doi.org/10.1016/S2213-8587(20)30426-5 PMID:33347808
  267. Vaccarella S, Ginsburg O, Bray F (2021). Gender inequalities in cancer among young adults. Lancet Oncology. 22(2): 166-167. https://doi.org/10.1016/S1470-2045(21)00001-2 PMID:33539738
  268. Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schuz J, et al. (2021). Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes and Endocrinology. 9(3): 144-152. https://doi.org/10.1016/S2213-8587(20)30401-0 PMID:33482107
  269. Yang Z, Yang J, Li MM, Chen JJ, Ou CQ (2021). Nonlinear and lagged meteorological effects on daily levels of ambient PM2.5 and O-3: Evidence from 284 Chinese cities. Journal of Cleaner Production. 278: 10. https://doi.org/10.1016/j.jclepro.2020.123931
  270. Znaor A, Fouad H, Majnoni d’Intignano F, Hammerich A, Slama S, Pourghazian N, et al. (2021). Use of cancer data for cancer control in the Eastern Mediterranean Region: Results of a survey among population-based cancer registries. International Journal of Cancer. 148(3): 593-600. https://doi.org/10.1002/ijc.33223 PMID:32683692
  271. Znaor A, Ryzhov A, Corbex M, Pineros M, Bray F (2021). Cervical cancer in the Newly Independent States of the former Soviet Union: Incidence will remain high without action. Cancer Epidemiology. 73: 101944. https://doi.org/10.1016/j.canep.2021.101944 PMID:33975255

 

 
View Key Publications

 

 

Cancer Surveillance
About Research Publications Related websites Personnel
Close Reading Mode
UP